KIMBERLY VANMEETEREN: Open Payments
NPI 1558937367 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 17 payments from 11 companies in 2025. Trend: 2023 $70 · 2024 $1,583 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $148 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $117 |
| Abbott Laboratories | 2 | $98 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: FABRAZYME, LifeVest, AVEIR, LEQVIO, Kerendia, AMVUTTRA, AQUAMANTYS(TM), REPATHA.
Industry payments across SD — which companies pay providers there.
